INDEX
A
Acidification................................................. 329, 336, 337
Adherens junctions (AJs) .................................... 7, 31, 43,
44, 66, 67, 76, 77, 120, 121, 128, 129, 149, 200,
304, 316
Adhesion
cell-cell ....................................... 15, 16, 49, 253, 257,
272, 276, 280, 346, 385, 415
cell-matrix .................................................... 15, 16, 43,
243, 258, 268, 272
Aggregates ..................................... 46, 47, 253, 275–285,
297, 298
B
Bioenergetics .............................................. 328, 329, 331,
333, 334, 336, 338
C
Cadherin
E-Cadherin (CDH1) ....................................... 44, 371
N-Cadherin (CDH2).............................................. 371
Cancer
associated fibroblasts ............................................... 244
breast................................................... 30, 50, 53, 244,
329, 354, 391, 392
colorectal .......................................161, 328, 391, 392
Carcinoma ...................................14, 20, 37, 48, 52, 200,
244, 303, 315, 316, 328
Cell
behaviour ..................................................... 21, 53, 80,
145, 174, 200, 228
culture ...................................... 44, 90, 190, 192, 229,
239, 244–247, 249, 265, 267, 270, 271, 290,
292, 293, 297, 331, 332, 338, 343, 355,
360–362, 416
dissociation ....................................... 36, 90, 267, 271,
307, 318, 320, 325
dynamics ......................................................... 187, 278
followers ..........................................96, 200, 244, 251
leaders .......................................................96, 244, 251
migrations........................................... 15, 53, 79–105,
173, 199–221, 228, 260, 266–267, 341, 354,
385, 415–424
tracking ................................. 136, 266, 267, 271, 282
Cell sorting
magnetic activated cell sorting ...................... 316, 321
Chromatin .........................................................51, 55, 80,
83–85, 87, 354, 369
Collective cell migrations ..............................15, 199–221
D
Diffusion.............................................145, 152, 155–157,
194, 310, 420
E
Electroporation .......................................... 110, 136, 184,
186, 188, 190, 191, 194
Embryo
chicken ........................................................... 107–114,
173–180, 184, 185, 188
Drosophila ...................................................... 9, 35, 54,
65–77, 145–157, 199–221
mouse......................................................135–144, 200
sea urchin.......................................................... 8, 9, 35
Xenopus ................................ 259, 266, 268, 277, 279
zebrafish..................................................................... 80
Endoderm..................................................... 7, 30, 35, 65,
115, 135, 174, 177, 257, 264, 269, 271
Epiblast ...................................................45, 48, 135, 136,
139, 143, 184, 186, 191, 194, 257, 341
Epithelial cells...................................................... 8, 15, 23,
35, 43–54, 65–67, 119, 157, 174, 227, 240, 275,
282, 290, 310, 317, 321, 337, 341–350, 354,
378, 402, 403, 405, 407
Epithelialization .......................................... 185, 280, 282
Epithelial-mesenchymal transition (EMT)
hybrid..............................................22, 353, 385, 386,
389, 392, 397–399, 401, 403, 405, 407, 408
partial .................................................. 4, 5, 10, 14, 23,
24, 29–32, 47, 48, 50, 116, 131, 162, 200, 316,
322, 353
pathological .............................. 21, 22, 30, 32, 44, 55
physiological ................................................ 21, 22, 30,
31, 183, 258, 354, 355, 363
Eversion ................................................................ 115–132
Kyra Campbell and Eric Theveneau (eds.), The Epithelial-to Mesenchymal Transition: Methods and Protocols,
Methods in Molecular Biology, vol. 2179, https://doi.org/10.1007/978-1-0716-0779-4,
© Springer Science+Business Media, LLC, part of Springer Nature 2021
427
A
Acidification................................................. 329, 336, 337
Adherens junctions (AJs) .................................... 7, 31, 43,
44, 66, 67, 76, 77, 120, 121, 128, 129, 149, 200,
304, 316
Adhesion
cell-cell ....................................... 15, 16, 49, 253, 257,
272, 276, 280, 346, 385, 415
cell-matrix .................................................... 15, 16, 43,
243, 258, 268, 272
Aggregates ..................................... 46, 47, 253, 275–285,
297, 298
B
Bioenergetics .............................................. 328, 329, 331,
333, 334, 336, 338
C
Cadherin
E-Cadherin (CDH1) ....................................... 44, 371
N-Cadherin (CDH2).............................................. 371
Cancer
associated fibroblasts ............................................... 244
breast................................................... 30, 50, 53, 244,
329, 354, 391, 392
colorectal .......................................161, 328, 391, 392
Carcinoma ...................................14, 20, 37, 48, 52, 200,
244, 303, 315, 316, 328
Cell
behaviour ..................................................... 21, 53, 80,
145, 174, 200, 228
culture ...................................... 44, 90, 190, 192, 229,
239, 244–247, 249, 265, 267, 270, 271, 290,
292, 293, 297, 331, 332, 338, 343, 355,
360–362, 416
dissociation ....................................... 36, 90, 267, 271,
307, 318, 320, 325
dynamics ......................................................... 187, 278
followers ..........................................96, 200, 244, 251
leaders .......................................................96, 244, 251
migrations........................................... 15, 53, 79–105,
173, 199–221, 228, 260, 266–267, 341, 354,
385, 415–424
tracking ................................. 136, 266, 267, 271, 282
Cell sorting
magnetic activated cell sorting ...................... 316, 321
Chromatin .........................................................51, 55, 80,
83–85, 87, 354, 369
Collective cell migrations ..............................15, 199–221
D
Diffusion.............................................145, 152, 155–157,
194, 310, 420
E
Electroporation .......................................... 110, 136, 184,
186, 188, 190, 191, 194
Embryo
chicken ........................................................... 107–114,
173–180, 184, 185, 188
Drosophila ...................................................... 9, 35, 54,
65–77, 145–157, 199–221
mouse......................................................135–144, 200
sea urchin.......................................................... 8, 9, 35
Xenopus ................................ 259, 266, 268, 277, 279
zebrafish..................................................................... 80
Endoderm..................................................... 7, 30, 35, 65,
115, 135, 174, 177, 257, 264, 269, 271
Epiblast ...................................................45, 48, 135, 136,
139, 143, 184, 186, 191, 194, 257, 341
Epithelial cells...................................................... 8, 15, 23,
35, 43–54, 65–67, 119, 157, 174, 227, 240, 275,
282, 290, 310, 317, 321, 337, 341–350, 354,
378, 402, 403, 405, 407
Epithelialization .......................................... 185, 280, 282
Epithelial-mesenchymal transition (EMT)
hybrid..............................................22, 353, 385, 386,
389, 392, 397–399, 401, 403, 405, 407, 408
partial .................................................. 4, 5, 10, 14, 23,
24, 29–32, 47, 48, 50, 116, 131, 162, 200, 316,
322, 353
pathological .............................. 21, 22, 30, 32, 44, 55
physiological ................................................ 21, 22, 30,
31, 183, 258, 354, 355, 363
Eversion ................................................................ 115–132
Kyra Campbell and Eric Theveneau (eds.), The Epithelial-to Mesenchymal Transition: Methods and Protocols,
Methods in Molecular Biology, vol. 2179, https://doi.org/10.1007/978-1-0716-0779-4,
© Springer Science+Business Media, LLC, part of Springer Nature 2021
427